<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent reports have suggested that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are organized in <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> populations </plain></SENT>
<SENT sid="1" pm="."><plain>Within these populations, a small subpopulation of cells is more capable of initiating <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>; these are called <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, HT-29 cells were sorted according to the presence or absence of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell marker CD133 </plain></SENT>
<SENT sid="3" pm="."><plain>We confirmed that CD133+ cells possessed higher clonogenicity compared to CD133- cells </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, proteomic analysis identified 10 proteins, including actin-related protein 2/3 complex subunit 5-like and profilin 2 </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, our data demonstrated that the expression of specific proteins associated with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and invasion in CD133+ cells contributed to the stemness and tumorigenic properties of these cells </plain></SENT>
</text></document>